Skip to main content
Karolinska Development logo

Karolinska Development — Investor Relations & Filings

Ticker · KDEV ISIN · SE0002190926 LEI · 54930011ZA52NKO5W681 ST Financial and insurance activities
Open in API
Filings indexed 761 across all filing types
Latest filing 2015-08-26 Report Publication Anno…
Country SE Sweden
Listing ST KDEV

About Karolinska Development

https://www.karolinskadevelopment.com/en

Karolinska Development is an investment company specializing in the life sciences sector. It identifies, finances, and supports the creation and growth of companies developing innovative medical technologies and pharmaceuticals. The firm manages a diversified portfolio of biotechnology and medtech ventures, often originating from academic research, with the goal of developing ground-breaking treatments for severe diseases. Karolinska Development leverages its team's expertise in research, development, and commercialization to guide its portfolio companies, providing both capital and strategic support to advance innovations toward the market.

Recent filings

Filing Released Lang Actions
Report Publication Announcement 2015
Report Publication Announcement Classification · 1% confidence The document is explicitly titled "Karolinska Development – Interim Report January – June 2015" and states that the company "today publishes its interim report January – June 2015." It contains detailed financial updates for the second quarter (Q2) and the first half of the year (January - June), including net profit/loss and portfolio fair value changes. This content aligns perfectly with the definition of a comprehensive financial report for a period shorter than a year, which corresponds to the Interim / Quarterly Report (IR) category. Although it mentions a conference call and that the full report is available on the website, the provided text *is* the substance of the report itself, not just an announcement of its publication (which would be RPA/RNS).
2015-08-26 English
Karolinska Development implements a more prudent and representative approach to reporting the fair value of its portfolio - divestment of Pharmanest
Net Asset Value Classification · 1% confidence The document is a press release dated July 9, 2015, announcing significant changes to the company's fair value reporting methodology (adopting a more prudent approach aligned with IPEV guidelines) and the divestment of a portfolio company (Pharmanest). It details the resulting financial impact (reductions in fair value) and mentions that these figures will be confirmed in the forthcoming Q2 report, which will also include a retrospective restatement. The content focuses on management decisions regarding valuation, portfolio strategy, and a specific transaction (divestment). This aligns best with an Earnings Release (ER) which often includes key operational and financial highlights outside of the formal quarterly report, or potentially a Management Report (MDA) if it were more detailed. However, since it is an announcement of financial adjustments and a transaction, and it explicitly points forward to the Q2 report for confirmation and restatement, it functions as a major financial update/release. Given the focus on financial results adjustments and strategic moves, 'ER' (Earnings Release) is the most appropriate fit for a major, unscheduled financial announcement of this nature, even though it's not a standard quarterly release announcement itself. It is not a full report (10-K or IR), nor is it a presentation (IP) or a call transcript (CT). It is a significant financial announcement.
2015-07-09 English
Karolinska Development implementerar ett försiktigare och mer representativt sätt att rapportera verkligt värde av portföljen samt avyttrar Pharmanest
Earnings Release Classification · 1% confidence The document is a press release dated July 9, 2015, announcing significant changes to the company's valuation methodology (implementing IPEV guidelines, shifting from DCF for early-stage companies) and the divestiture of a portfolio company (Pharmanest). It also discusses revisions related to an agreement with Rosetta Capital and provides updated portfolio value figures as of June 30, 2015. Crucially, it states that the finalized values and comparisons will be confirmed in the upcoming 'delårsrapport för årets andra kvartal' (interim report for the second quarter) to be published on August 26, 2015. Since this document is an announcement detailing financial changes, strategic shifts, and providing context *before* the official quarterly report release, it functions as a major corporate disclosure. It is not the full Interim Report (IR) itself, nor is it a standard Earnings Release (ER) which usually focuses only on key results. Given its nature as a significant, non-standard financial/strategic update that precedes a formal periodic report, it best fits the category for general regulatory announcements or significant corporate news that doesn't fit other specific codes. However, because it details significant changes in financial reporting and valuation methods, which are core components of financial reporting, and it is a press release format, it is most closely aligned with a major corporate announcement. Since it is not a standard 10-K, IR, or ER, and it is not explicitly announcing the *publication* of a report (RPA), the most appropriate general category for significant, non-standard corporate disclosures is Regulatory Filings (RNS). If a more specific category existed for 'Major Financial/Valuation Update Press Release', that would be ideal, but based on the provided list, RNS serves as the best fit for this type of material disclosure. H1 2015
2015-07-09 Swedish
Karolinska Developments årsstämma 2015
AGM Information Classification · 1% confidence The document is titled "Karolinska Developments årsstämma 2015" (Karolinska Development's Annual General Meeting 2015) and details the resolutions passed by the shareholders on May 20, 2015. Key actions mentioned include the approval of financial statements, allocation of profit, granting of discharge to the board, election of board members and auditors, and approval of remuneration guidelines and stock programs. These are all standard items discussed and voted upon at an Annual General Meeting (AGM). Therefore, the document is classified as AGM Information.
2015-05-21 Swedish
Karolinska Development´s Annual General Meeting 2015
AGM Information Classification · 1% confidence The document is explicitly titled "Karolinska Development’s Annual General Meeting 2015" and details the resolutions passed during the meeting held on May 20, 2015. It covers topics like profit allocation, election of directors and auditors, and shareholder authorizations, which are the core components of an AGM proceeding report. This directly corresponds to the AGM Information (AGM-R) definition.
2015-05-21 English
Interim / Quarterly Report 2015
Interim / Quarterly Report Classification · 1% confidence The document is a comprehensive quarterly financial report for Karolinska Development, covering the first quarter (Q1) of 2015. It includes detailed financial statements (income statement, balance sheet), key performance indicators, management commentary (CEO's report), and operational updates on portfolio companies. It is not a short announcement, but a substantive report containing actual financial data, fitting the definition of an Interim/Quarterly Report. Q1 2015
2015-05-06 Swedish

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.